1.
Antimicrob Agents Chemother
; 50(4): 1578-80, 2006 Apr.
Artículo
en Inglés
| MEDLINE
| ID: mdl-16569890
RESUMEN
To compare the effect of ritonavir on plasma amprenavir pharmacokinetics, healthy adults received either fosamprenavir (700 mg twice a day [BID]) or amprenavir (600 mg BID) alone and in combination with ritonavir (100 mg BID). Ritonavir increased plasma amprenavir pharmacokinetic parameters to a similar extent when coadministered with either fosamprenavir or amprenavir.